Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells (Q38918317)

7 September 2017

title

Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells (English)

1 reference

7 September 2017

1 reference

Katharina Hammer

1

1 reference

7 September 2017

Adam Kazcorowski

2

1 reference

7 September 2017

Li Liu

3

1 reference

7 September 2017

Michael Behr

4

1 reference

7 September 2017

Peter Schemmer

5

1 reference

7 September 2017

Ingrid Herr

6

1 reference

7 September 2017

Dirk M Nettelbeck

7

1 reference

7 September 2017

language of work or name

English

0 references

publication date

20 February 2015

1 reference

International Journal of Cancer

7 September 2017

published in

1 reference

7 September 2017

volume

137

1 reference

7 September 2017

issue

4

1 reference

7 September 2017

page(s)

978-990

1 reference

7 September 2017

cites work

Oncolytic virotherapy

1 reference

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

21 January 2018

1 reference

Current issues and future directions of oncolytic adenoviruses

21 January 2018

1 reference

Cell carriers for oncolytic viruses: Fed Ex for cancer therapy

21 January 2018

1 reference

Carrier cell-mediated delivery of a replication-competent adenovirus for cancer gene therapy

21 January 2018

1 reference

Concise Review: Mesenchymal Stem Cell Tumor-Homing: Detection Methods in Disease Model Systems

21 January 2018

1 reference

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

Mesenchymal stem cells and cancer: tumor-specific delivery vehicles or therapeutic targets?

21 January 2018

1 reference

Approaches to utilize mesenchymal progenitor cells as cellular vehicles

21 January 2018

1 reference

Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma

21 January 2018

1 reference

Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma

21 January 2018

1 reference

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

21 January 2018

1 reference

Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors

21 January 2018

1 reference

Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells

21 January 2018

1 reference

Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model

21 January 2018

1 reference

Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study.

21 January 2018

1 reference

Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells.

21 January 2018

1 reference

Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors

21 January 2018

1 reference

Fiber-modified adenovirus vectors mediate efficient gene transfer into undifferentiated and adipogenic-differentiated human mesenchymal stem cells

21 January 2018

1 reference

Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors

21 January 2018

1 reference

A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer

21 January 2018

1 reference

Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.

21 January 2018

1 reference

Armed replicating adenoviruses for cancer virotherapy

21 January 2018

1 reference

The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models

21 January 2018

1 reference

Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers

21 January 2018

1 reference

TRAIL on trial: preclinical advances in cancer therapy

21 January 2018

1 reference

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

TRAIL gene therapy: from preclinical development to clinical application

21 January 2018

1 reference

Human CD34 cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature

21 January 2018

1 reference

A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases.

21 January 2018

1 reference

Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter

21 January 2018

1 reference

Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter

21 January 2018

1 reference

TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells

21 January 2018

1 reference

TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo

21 January 2018

1 reference

Selectivity and Efficiency of Late Transgene Expression by Transcriptionally Targeted Oncolytic Adenoviruses Are Dependent on the Transgene Insertion Strategy

21 January 2018

1 reference

Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.

21 January 2018

1 reference

Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase gene directed by the rat insulin promoter

21 January 2018

1 reference

Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method

21 January 2018

1 reference

Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system

21 January 2018

1 reference

Suitability of human mesenchymal stem cells for gene therapy depends on the expansion medium

21 January 2018

1 reference

Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells

21 January 2018

1 reference

Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy

21 January 2018

1 reference

Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector

21 January 2018

1 reference

Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus

21 January 2018

1 reference

Antitumor activity of Ad-IU2, a prostate-specific replication-competent adenovirus encoding the apoptosis inducer, TRAIL.

21 January 2018

1 reference

Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas

21 January 2018

1 reference

Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death

21 January 2018

1 reference

On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29442

1 reference

7 September 2017

1 reference